Thomas A. Fitzgerald - Interim CEO, CFO, Director at Transcode Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO, CFO, Director
Stock Symbol
RNAZ on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas A. Fitzgerald since 11/3/2023

Holdings reported by Thomas A. Fitzgerald for Transcode Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 56.3K $28.7K $0.51 Sep 28, 2023 Direct
Stock Option (right to buy) 650K Jun 14, 2024 Direct Common Stock

Transactions reported by Thomas A. Fitzgerald for Transcode Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.